Searchable abstracts of presentations at key conferences in endocrinology

ea0063p44 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Comparative study between autoimmune metaplastic atrophic gastritis (AMAG) and type 1 gastric neuroendocrine tumors (G-NETs) in Hospital Clínico San Carlos (HCSC), Madrid

Ramos Elvira , Vargas-Zuniga Ignacio , Barrio Elvira , Suarez Pablo , Pazos Mario , Pallares Raquel , Aldama Paula , De La Torre Nuria Garcia , Sevilla Concepcion , Diaz Jose Angel

Introduction: Type 1 Gastric neuroendocrine tumors account for 70 to 80 percent of all gastric neuroendocrine tumors (G-NETs) and they are found more commonly in older adults, particularly women. They are associated with autoimmune metaplastic atrophic gastritis (AMAG) with or without pernicious anemia. Endoscopically, they are usually smaller than 1 cm and often multiple. These tumors usually present a non-aggressive evolution. Our goal is to approach the presence of risk fac...

ea0081p68 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Development and validation of a new gestational diabetes mellitus (gdm) risk algorithm

Mendizabal Leire , Arregui Maddi , Valerio Johanna , Ramos Ana Maria , Barabash Ana , de la Torre Nuria Garcia , zulueta mirella , Arana Eunate , Saez Eva , Aranbarri Igotz , Martinez-Lage Juan , Cortazar Alicia , Gaztambide Sonia , Castano Luis , Simon Laureano , Luis Calle-Pascual Alfonso

Background and Objective: Gestational Diabetes Mellitus (GDM) is associated with life-long adverse outcomes for the mother and the baby. To date there is no rigorous clinical test for the assessment of GDM risk, since estimation of GDM risk is currently primarily based on clinical risk factors. Additional markers are needed to identify women at high risk. Our aim was to develop and validate a risk assessment model to identify women at high risk of GDM through an algorithm that...

ea0062p17 | Poster Presentations | EU2019

Self-diagnosis of De la Chapelle syndrome

Ahmad Sajjad , Ravindran Ravikumar , Lansdown Andrew

Case history: A 30 years old male Caucasian had his saliva tested on a self-funded commercial DNA testing to identify his ancestral roots. The markers for Y chromosome were found to be absent and further evaluation revealed him to have 46 XX karyotype.This was consistent with the diagnosis of De la Chapelle syndrome or XX male syndrome. Fluorescence in situ hybridization (FISH) studies confirmed the presence of SRY (sex determining region Y) gene which was responsible...

ea0032p383 | Diabetes | ECE2013

Study of the development and validation of the specific “Satiglu” questionnaire to evaluate the satisfaction of diabetic patients with glucometers

Portillo Cristobal Morales , Garcia Clara Garcia , Sanlaureano Florentino Carral , Huerga Juan Carlos , Casares Martin Lopez de la Torre , Hurtado Javier

Objective: To develop a specific questionnaire to evaluate the satisfaction of diabetic patients with the use of glucometers and evaluate their psychometric properties (feasibility, reliability, and validity).Material and methods: Two stages: i) questionnaire development: a set of 53 items was constructed after a bibliographic review. A panel of six experts and 50 patients concluded a 25-item version of the questionnaire (dimensions: satisfaction, inconv...

ea0026p597 | Clinical case reports | ECE2011

Use of our last pills of iopanoic acid in a 33-year-old patient in acute refractory pulmonary edema and thyroid storm: requiem for a useful therapeutic agent

Hoyos E Gomez , Novoa P de Miguel , Zorrilla C Montanez , de la Torre N Garcia , Freixes M Curras , Freire R Bover , Pascual A Calle , de la Vega I Runkle

Introduction: The contrast agents iopanoic acid and ipodate are potent inhibitors of thyroid function, reducing type I deodinase T3 generation, inhibiting thyroid liberation of T4 and T3, and T3 receptor binding, with off-label use in hyperthyroid emergencies. However, since the interruption of iopanoic acid production this year, neither agent is currently available in Spain.Case report: A 34-year-old male was ...

ea0049ep401 | Developmental endocrinology | ECE2017

Nutritional status in ambulatory patients by Medicine Laboratory

De La Torre Francisco Javier Merida , Bel Pena Nieves

Nutritional status has an important effect on the progression of any disease, not only in hospitalized patients, even more in ambulatory patient of primary care. Although there are many systems of evaluating nutritional status, they are costly and subject to variability amongst individuals. The Medicine Laboratory can correctly perform a nutritional evaluation in a quick an efficient manner.Objective: Analyze the nutritional status by CONUT nutritional e...

ea0056p520 | Endocrine Disruptors | ECE2018

Cognitive impairment and nutritional status in patients admitted to the Department of Internal Medicine

Merida De la Torre Francisco J , Bel Pena Nieves

Introduction: Altered nutritional status is a problem in itself that can complicate a patient’s disease. In our hospital, the assessment of nutritional status at hospital admission is protocolized and performed by the Clinical Laboratory automatically, through the CONUT system, for three years ago. Our hospital provides assistance to a population of 120,000 patients, from rural areas and with a high average age. Hospital admissions for cognitive impairment are increasing ...

ea0037ep783 | Pituitary: clinical | ECE2015

Long-term recurrence in nonfunctional pituitary adenomas after surgery

Caballero Maria Galiana Rodriguez , Gallego Nuria Valdes , Blanco Jessica Ares , Ragnarsson Cecilia Sanchez , Cacho Laura , de la Uz Joaquin Pertierra , Artal Antonio Rabal , Gutierrez Lorena Suarez , Delgado Elias , Camblor Pablo Martinez , Faedo Ceferino , Torre Edelmiro Menendez

Object: Nonfunctioning pituitary adenomas can experiment recurrence and/or progression (R/P) several years after surgery in about 15–50% of patients. There is few evidence about risk factors that could predict R/P. The aim of this study is to identify them and describe our experience through a long term of follow-up in pituitary macroadenomas.Methods: Retrospective cohort analysis of 64 patients who underwent surgery between 1990 and 2013. The main ...

ea0037ep821 | Pituitary: clinical | ECE2015

Study of the prevalence and related factors in the withdrawal of medical treatment macroprolactinomas

Gutierrez Lorena Suarez , Caballero Maria Galiana Rodriguez , Ragnarson Cecilia Sanchez , Garcia Nuria Valdes , Garcia Laura Cacho , Torre Edelmiro Menendez

Introduction: The prolactinoma is the most common functioning pituitary tumour. There are few long-term studies on the optimal duration of treatment with dopamine agonists prolactinoma to ensure healing without recurrence after stopping the medication and do not provide a consensus on it or on withdrawal criteria treatment.Objectives: To establish the prevalence of withdrawal of treatment macroprolactinomas and evaluate criteria prolactinoma cure medical...

ea0056p432 | Diabetes complications | ECE2018

Association of adverse pregnancy outcomes with glycemic cut-offs stated by the IADPSG, POGS and WHO diagnostic criteria for gestational diabetes mellitus in De La Salle University Medical Center (DLSUMC), Cavite, Philippines from January 2012 to December 2015

Francisco Danica , Andag-Silva Aimee

Objectives: To determine the association between adverse pregnancy outcomes with each of the 75 g OGTT cut-off values prescribed by the World Health Organization (WHO), Philippine Obstetrical and Gynecological Society (POGS), and the International Association of Diabetes in Pregnancy Study group (IASDPG) criteria to help define more appropriate glycemic cut-off levels for Filipinas.Methodology: Retrospective Cohort study of pregnancy deliveries in De La ...